Electrochemotherapy compared with standard radiotherapy for basal cell skin cancer
Compares electrochemotherapy with standard radiotherapy for small basal cell skin cancers in adults.
Plain-language title generated from the registry record
Registry title: Electrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinoma
Key facts
- Where
- Herlev, DenmarkSee the site
- Phase
- Phase 4
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with biopsy-confirmed basal cell carcinoma, a type of skin cancer, smaller than 3 cm (1.2 in). It compares electrochemotherapy with standard radiotherapy.
- Age
- Above 18 years
- Sex
- All sexes
- Disease stage
- Basal cell carcinoma confirmed by biopsy, under 3 cm (1.2 in), that can be treated with both radiotherapy and electrochemotherapy
- Earlier treatment
- Previous bleomycin above 200.000 Units/m2 is not allowed
Main reasons for not taking part
- Basal cell carcinoma that has spread (metastatic)
- Previous bleomycin above 200.000 Units/m2
- Previous severe allergic reaction to bleomycin
- Pregnancy or breast feeding
- Taking part in other trials with trial medication
Read by machine on 9 November 2026.
Where in Denmark
- Region HovedstadenHerlev, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorTrial details
- Who runs it
- Region Hovedstaden
- Trial code
- EU 2024-519066-49-01
- Record updated
- 16 December 2024
- Original description
To compare effect of electhrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinomas less than 3 cm.Read full original descriptionShow less
Electrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinoma
To compare effect of electhrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinomas less than 3 cm.
Inclusion: Age above 18 years; Biopsy verified basal cell carcinoma under 3 cm accessible for both radiotherapy and elechtrochemoterapy; Subject must understand patient information; Signed informed consent.
Exclusion: Previous treatment with bleomycin above 200.000 Units/m2; Previous severe allergic reactions to bleomycin; Participation in other trials with trial medication; Metastatic basal cell carcinoma; Pregnancy or breast feeding.